MW 374.3 Da, Purity >98%. Potent, competitive, selective and cell-permeable inhibitor of CaM-KK (Ki values are0.21 μM and 40 nM for CaM-KKα and CaM-KKβ respectively). Potent, competitive AhR agonist (EC50 = 43 nM). Active in vivo..
1810038L18Rik, CAMKK, CAMKK alpha protein, CAMKK beta protein, CAMKKA, CAMKKB, CK II, CK II alpha, CK II alpha', CK II beta, CK2A1, CK2A2, CK2B, CK2N, CSK21_HUMAN, CSK22_HUMAN, CSK2B_HUMAN, CSNK 2B, Ca2+/calmodulin-dependent protein kinase kinase alpha, CaM-KK 1, CaM-KK alpha, CaM-KK beta, CaM-kinase IV kinase, CaM-kinase kinase 1, CaM-kinase kinase 2, CaM-kinase kinase alpha, CaM-kinase kinase beta, Calcium/calmodulin dependent protein kinase beta, Calcium/calmodulin dependent protein kinase kinase, Calcium/calmodulin dependent protein kinase kinase 1 alpha, Calcium/calmodulin dependent protein kinase kinase 2 beta, Calcium/calmodulin-dependent protein kinase kinase 1, Calcium/calmodulin-dependent protein kinase kinase 2, Calcium/calmodulin-dependent protein kinase kinase alpha, Calcium/calmodulin-dependent protein kinase kinase beta, Casein kinase 2 alpha prime polypeptide, Casein kinase 2 beta polypeptide, Casein kinase II alpha chain, Casein kinase II alpha' chain, Casein kinase II beta subunit, Casein kinase II subunit alpha, Casein kinase II subunit alpha', Casein kinase II subunit beta, Casein kinase II, alpha 1 polypeptide, Casein kinase II, alpha 1 related sequence 4, Csnk2a1-rs4, DKFZp761M0423, DYRK2_HUMAN, Dual specificity tyrosine (Y) phosphorylation regulated kinase 2, Dual specificity tyrosine-phosphorylation-regulated kinase 2, EC 2.7.12.1, FLJ21217, FLJ21365, FLJ43934, G5A, KKCC1_HUMAN, KKCC2_HUMAN, Kid 1, Kinase induced by depolarization, MAP kinase interacting kinase 1, MAP kinase interacting serine/threonine kinase 1, MAP kinase signal-integrating kinase 1, MAP kinase-interacting serine/threonine-protein kinase 1, MAPK signal integrating kinase 1, MGC102141, MGC138222, MGC138224, MGC34095, MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1, MKNK1_HUMAN, ONCOGENE PIM3, OTTHUMP00000025825, OTTMUSP00000006419, OTTMUSP00000016898;, PIM2_HUMAN, PIM3_HUMAN, Phosvitin, Pim 2 oncogene, Pim 3 oncogene, Pim-2h, Pim-3 proto-oncogene, serine/threonine kinase, Protein G5a, Protein kinase Kid 1, Proto Oncogene PIM2, Proto-oncogene Pim-2 (serine threonine kinase), RP23-452D3.3, Serine/threonine kinase PIM2, Serine/threonine kinase Pim 3, Serine/threonine-protein kinase Pim-2, Serine/threonine-protein kinase Pim-3
MW 374.3 Da, Purity >98%. Potent, competitive, selective and cell-permeable inhibitor of CaM-KK (Ki values are0.21 μM and 40 nM for CaM-KKα and CaM-KKβ respectively). Potent, competitive AhR agonist (EC50 = 43 nM). Active in vivo..
Soluble in DMSO to 25 mM.
Potent, competitive, selective and cell-permeable inhibitor of CaM-KK (Ki values are0.21 μM and 40 nM for CaM-KKα and CaM-KKβ respectively). Potent, competitive AhR agonist (EC50 = 43 nM). Active in vivo.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141591, STO-609 acetate, CaM-KK inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com